Insulet
PODD
#1041
Rank
HK$146.14 B
Marketcap
HK$2,083
Share price
9.40%
Change (1 day)
72.02%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): HK$13.47

According to Insulet's latest financial reports the company's current EPS (TTM) is HK$13.37. In 2022 the company made an earnings per share (EPS) of HK$0.54 a decrease over its 2021 EPS that were of HK$1.79.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$13.472376.06%
2022HK$0.54-69.57%
2021HK$1.79109.09%
2020HK$0.86-38.89%
2019HK$1.40200%
2018HK$0.47-113.04%
2017-HK$3.58-9.8%
2016-HK$3.96-60.77%
2015-HK$10.1139.78%
2014-HK$7.2312.05%
2013-HK$6.45-23.15%
2012-HK$8.4010.2%
2011-HK$7.62-36.36%
2010-HK$11.97-36.63%
2009-HK$18.89-29.36%
2008-HK$26.74-86.74%
2007-HK$201.70-64.04%
2006-HK$560.90122.23%
2005-HK$252.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$15.70-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$25.11-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$7.62-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.50 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$23.11 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$21.15 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
HK$42.21 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA